David Apelian

This inventor holds 21 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 7 EPO patents, primarily in Immunotherapy Research. Top assignees: Globeimmune, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Apelian. Retrieved from https://idiyas.com/inventor/david-apelian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 7)

% Patents Active = 90.5

CIPO Patents = 4

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 81(Granted Patents)

Location History:

Booton Township, NJ (US) (2014 - 2015)
Boonton Township, NJ (US) (2013 - 2024)

Company Filing History:

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

Areas of Expertise:

Yeast-Brachyury

Immunotherapy

HIV Treatment

Hepatitis B

Hepatitis C

Chronic Infections

Cancer Therapies

Therapeutic Compositions

Infection Prevention

Research Compositions

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11944673 - Yeast-brachyury immunotherapeutic compositions (2024-04-02),

2. 11938175 - Yeast-brachyury immunotherapeutic compositions (2024-03-26),

3. 10849971 - Compositions and methods for the treatment or prevention of human immunodeficiency virus infection (2020-12-01),

4. 10507235 - Yeast-based immunotherapy for Chordoma (2019-12-17),

5. 10441650 - Compositions and methods for the treatment or prevention of hepatitis B virus infection (2019-10-15),

6. 10363294 - Yeast-brachyury immunotherapeutic compositions (2019-07-30),

7. 10265393 - Compositions and methods for the treatment or prevention of human immunodeficiency virus infection (2019-04-23),

8. 9987352 - Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection (2018-06-05),

9. 9943591 - Compositions and methods for the treatment or prevention of hepatitis B virus infection (2018-04-17),

10. 9782473 - Compositions and methods for the treatment or prevention of human immunodeficiency virus infection (2017-10-10),

11. 9623097 - Yeast-brachyury immunotherapeutic compositions (2017-04-18),

12. 9579377 - Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection (2017-02-28),

13. 9428556 - Compositions and methods for the treatment or prevention of hepatitis B virus infection (2016-08-30),

14. 9290547 - Yeast-based therapeutic for chronic hepatitis B infection (2016-03-22),

15. 9254320 - Compositions and methods for the treatment or prevention of human adenovirus-36 infection (2016-02-09),

Title: The Innovative Journey of David Apelian

Introduction: David Apelian, a distinguished inventor hailing from Boonton Township, NJ, has made significant contributions to the field of technology and innovation.

Latest Patents: David Apelian holds several patents in the realm of materials science and engineering, showcasing his expertise and creativity in developing novel solutions to complex problems.

Career Highlights: With a career spanning over two decades, David Apelian has held key positions in various tech companies, leading groundbreaking projects and driving innovation in the industry.

Collaborations: Throughout his career, David Apelian has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and knowledge sharing to push the boundaries of technological advancements.

Conclusion: David Apelian's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology with his groundbreaking contributions.

Profile summary based on public USPTO records.